Table 1
Demographic details of the cohort of patients, their biometry, and their refractive and visual results
| No | Age | Sex | Preop refraction | Preop spherical equivalent | Preop BSCVA | Axial length | Formula | Follow up (months) | Postop refraction | Postop spherical equivalent | Postop BSCVA |
| 1 | 60 | M | +9.50–2.00 × 100 | +8.5 | 6/18 | 19.95 | SRK/II | 47.00 | +1.25–1.75 × 140 | +0.375 | 6/12 |
| 2 | 60 | M | +8.50–2.00 × 45 | +7.5 | 6/18 | 20.72 | SRK/T | 44.00 | +2.25–1.50 × 40 | +1.5 | 6/12 |
| 3 | 84 | F | +7.75–1.25 × 75 | +7.125 | HM | 19.44 | SRK/T | 31.00 | +0.25–2.75 × 108 | −1.125 | HM |
| 4 | 84 | F | +7.25–0.75 × 75 | +6.875 | HM | 20.27 | SRK/T | 29.00 | −0.00–0.50 × 162 | −1.25 | HM |
| 5 | 84 | F | +5.75–1.50 × 80 | +5 | 6/18 | 21.12 | SRK/II | 41.00 | +2.75–2.75 × 96 | +1.375 | 6/18 |
| 6 | 70 | F | +7.50–3.00 × 105 | +6 | 6/12 | 20.73 | SRK/II | 29.00 | +3.50–3.00 × 122 | +2 | 2/60 |
| 7 | 91 | F | +9.00–2.00 × 70 | +8 | 6/18 | 19.23 | SRK/II | 20.00 | +2.00–2.00 × 90 | +1 | 6/12 |
| 8 | 82 | F | Plano | 0 | 6/18 | 20.83 | SRK/II | 13.00 | −1.25–1.25 × 95 | −1.875 | 6/5 |
| 9 | 83 | F | +3.50–0.50 × 60 | +3.25 | 6/12 | 20.70 | SRK/T | 13.00 | −0.50–0.75 × 90 | −0.875 | 6/12 |
| 10 | 83 | F | +2.75–0.25 × 30 | +2.625 | 6/12 | 20.85 | SRK/T | 13.00 | −0.50–2.50 × 90 | −1.75 | 6/9 |
| 11 | 94 | F | Plano | 0 | HM | 20.43 | SRK/T | 11.00 | −1.00–2.50 × 101 | −2.25 | CF |
| 12 | 72 | F | +2.00–1.50 × 35 | +1.25 | 6/18+1 | 21.00 | SRK/T | 17.00 | −0.25sph | −0.25 | 6/9+3 |
| 13 | 71 | F | +9.25–1.00 × 75 | +8.75 | 6/12 | 20.27 | SRK/T | 16.00 | +3.25–3.00 × 63 | +1.75 | 6/12 |
| 14 | 46 | F | +4.50–2.25 × 150 | +3.375 | HM | 20.59 | SRK/T | 15.00 | +0.50–1.50 × 20 | −0.25 | HM |
| 15 | 46 | F | +5.50–1.50 × 10 | +4.75 | PL | 20.43 | SRK/T | 15.00 | +0.75–1.75 × 110 | −0.125 | HM |
